GENETIC SCREENING AND DIAGNOSIS OF HUMAN DISEASES

Cambridge Symposia symposia at xensei.com
Thu Dec 19 14:34:28 EST 1996


For registration and hotel information please contact:

Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA  02164
USA

Phone: 617-630-1300
Fax: 617-630-1325
E-mail: chi at healthtech.com
http://www.healthtech.com/conferences/

Third Annual GENETIC SCREENING AND DIAGNOSIS OF HUMAN DISEASES	
February 27-28, 1997
Fairmont Hotel
San Francisco, California

Scientific Advisory Committee
     Dr. Ian Day, University College London Medical School
     Dr. Thomas J. Meade, California Institute of Technology
     Dr. David Moskowitz, St. Louis VA Medical Center
     Dr. M. Allen Northrup, Lawrence Livermore National Laboratory

Preventative Molecular Medicine The Future of Molecular Medicine
             Dr. Arno Motulsky, University of Washington 
Current Methods to Find Disease Genes
             Dr. Richard King, University of Minnesota 
Basic Statistical Issues in Linkage Analysis and Association
	Dr. Robert C. Elston, Case Western Reserve University
Interim Report from Task Force of Genetic Testing
	Dr. Neil A. Holtzman, Johns Hopkins University 
Individual Life Insurance, Risk Classification, and Genetics
	Dr. Robert Gleeson, Northwestern Mutual Life Insurance
Insurance Issues Inherent in Medical Genetics and Molecular Medicine
	Dr. Mary Kay Pelias, Genetics Society Fellow 

Advances in Technology 
The Advanced Technology Program:  Tools for DNA Diagnostics
     Dr. Stanley Abramowitz, National Institute of Standards and Tech.
Electron Transfer Mechanisms Through the DNA Double Helix
     Dr. Thomas J. Meade, California Institute of Technology 
Miniaturized Diagnostic Instruments
     Dr. M. Allen Northrup, Lawrence Livermore National Laboratory 
Polygenic Disease Diagnosis Using an Active Electronic Multiplex
Hybridization Device
     Dr. Michael J. Heller, Nanogen, Inc.
Gene-Callingä:  A Comprehensive System for Expression Monitoring
     Dr. Gregory Went, CuraGen Corporation
GeneSpectrometryä- Genotyping by MALDI Mass Spectrometry
     Dr. Lawrence Haff, PerSeptive Biosystems, Inc.
Managing Multigene Stratification Data
     Dr. Chris Fields, Molecular Informatics, Inc.

Molecular Diagnostics
Diagnostic Challenge of Multigene Diseases
     Dr. Margaret Bywater, OncorMed, Inc. 
Leveraging Genomic Databases for the Discovery of Diagnostic Markers
for Disease
     Dr. John Burczak, SmithKline Beecham Pharmaceuticals 
Diagnostic Applications of GeneChipä DNA Probe Arrays
     Dr. Robert Lipshutz, Affymetrix, Inc. 
High Throughput Generation and Analysis of Gene Expression Patterns
     Dr. Richard Kouri, Gene Logic, Inc. 
Use of Structure-Specific Cleavage Technology to Detect Mutations and
Quantitate Gene Expression in Clinically Significant Samples
     Dr. Lance Fors, Third Wave Technologies 
A Suite of Mutation Analysis Methodologies Founded on Microplate Array
Diagonal Gel Electrophoresis (MADGE)
     Dr. Ian Day, University College London Medical School 
Screening for Trinucleotide Repeat Expansions and the RED Method
     Dr. Martin Schalling, Karolinska Hospital, Sweden

Screening for Disease Susceptibility Genes
Is ACE D/D a Master Disease Genotype?
     Dr. David Moskowitz, St. Louis VA Medical Center 
Molecular Haplotyping of Genome Diversity 
     Dr. Gualberto Ruano, BIOS Laboratories
Molecular Genetics as a Tool in Clinical Trial Design
     Dr. Glenn A. Miller, Genzyme Genetics 
Use of Molecular Genetics in Patient and Disease Studies
     Dr. Wendy Fibison, National Center for Human Genome Research 
Genetic Susceptibility Testing in Alzheimer's Disease:  Methodological
and Ethical Issues
      Dr. Peter J. Whitehouse, University Hospitals of Cleveland,
      and Stephen Post, Case Western Reserve University





More information about the Methods mailing list